102 related articles for article (PubMed ID: 11848445)
1. The antimitogenic action of the sulphated polysaccharide fucoidan differs from heparin in human vascular smooth muscle cells.
Patel MK; Mulloy B; Gallagher KL; O'Brien L; Hughes AD
Thromb Haemost; 2002 Jan; 87(1):149-54. PubMed ID: 11848445
[TBL] [Abstract][Full Text] [Related]
2. Fucoidan inhibits smooth muscle cell proliferation and reduces mitogen-activated protein kinase activity.
Religa P; Kazi M; Thyberg J; Gaciong Z; Swedenborg J; Hedin U
Eur J Vasc Endovasc Surg; 2000 Nov; 20(5):419-26. PubMed ID: 11112459
[TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor-BB, insulin-like growth factor-I, and phorbol ester activate different signaling pathways for stimulation of vascular smooth muscle cell migration.
Pukac L; Huangpu J; Karnovsky MJ
Exp Cell Res; 1998 Aug; 242(2):548-60. PubMed ID: 9683541
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of extracellular signal-regulated protein kinases (ERKs) 1 and 2 by cAMP and dissociation of ERK inhibition from anti-mitogenic effects in rabbit vascular smooth muscle cells.
Cospedal R; Lobo M; Zachary I
Biochem J; 1999 Sep; 342 ( Pt 2)(Pt 2):407-14. PubMed ID: 10455028
[TBL] [Abstract][Full Text] [Related]
6. Rat aortic smooth muscle cell density affects activation of MAP kinase and Akt by menadione and PDGF homodimer BB.
Li XA; Bianchi C; Sellke FW
J Surg Res; 2001 Oct; 100(2):197-204. PubMed ID: 11592793
[TBL] [Abstract][Full Text] [Related]
7. Role of JNK, p38, and ERK in platelet-derived growth factor-induced vascular proliferation, migration, and gene expression.
Zhan Y; Kim S; Izumi Y; Izumiya Y; Nakao T; Miyazaki H; Iwao H
Arterioscler Thromb Vasc Biol; 2003 May; 23(5):795-801. PubMed ID: 12637337
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein D inhibits platelet-derived growth factor-BB-induced vascular smooth muscle cell proliferated by preventing translocation of phosphorylated extracellular signal regulated kinase 1/2 to the nucleus.
Sarjeant JM; Lawrie A; Kinnear C; Yablonsky S; Leung W; Massaeli H; Prichett W; Veinot JP; Rassart E; Rabinovitch M
Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2172-7. PubMed ID: 14551159
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein D and platelet-derived growth factor-BB synergism mediates vascular smooth muscle cell migration.
Leung WC; Lawrie A; Demaries S; Massaeli H; Burry A; Yablonsky S; Sarjeant JM; Fera E; Rassart E; Pickering JG; Rabinovitch M
Circ Res; 2004 Jul; 95(2):179-86. PubMed ID: 15192024
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of tetrandrine on the serum- and platelet-derived growth factor-BB-induced proliferation of rat aortic smooth muscle cells through inhibition of cell cycle progression, DNA synthesis, ERK1/2 activation and c-fos expression.
Fang LH; Zhang YH; Ma JJ; Du GH; Ku BS; Yao HY; Yun YP; Kim TJ
Atherosclerosis; 2004 Jun; 174(2):215-23. PubMed ID: 15136051
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II-augmented migration of VSMCs towards PDGF-BB involves Pyk2 and ERK 1/2 activation.
Blaschke F; Stawowy P; Kappert K; Goetze S; Kintscher U; Wollert-Wulf B; Fleck E; Graf K
Basic Res Cardiol; 2002 Jul; 97(4):334-42. PubMed ID: 12111044
[TBL] [Abstract][Full Text] [Related]
12. Phosphoinositide-dependent kinase 1 and p21-activated protein kinase mediate reactive oxygen species-dependent regulation of platelet-derived growth factor-induced smooth muscle cell migration.
Weber DS; Taniyama Y; Rocic P; Seshiah PN; Dechert MA; Gerthoffer WT; Griendling KK
Circ Res; 2004 May; 94(9):1219-26. PubMed ID: 15059930
[TBL] [Abstract][Full Text] [Related]
13. Heparin fails to inhibit the proliferation of human vascular smooth muscle cells in the presence of human serum.
Underwood PA; Mitchell SM; Whitelock JM
J Vasc Res; 1998; 35(6):449-60. PubMed ID: 9858870
[TBL] [Abstract][Full Text] [Related]
14. Modulation of human endothelial cell proliferation and migration by fucoidan and heparin.
Giraux JL; Matou S; Bros A; Tapon-Bretaudière J; Letourneur D; Fischer AM
Eur J Cell Biol; 1998 Dec; 77(4):352-9. PubMed ID: 9930660
[TBL] [Abstract][Full Text] [Related]
15. Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells.
Bilder GE; Krawiec JA; McVety K; Gazit A; Gilon C; Lyall R; Zilberstein A; Levitzki A; Perrone MH; Schreiber AB
Am J Physiol; 1991 Apr; 260(4 Pt 1):C721-30. PubMed ID: 1850195
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of tissue factor synthesis by disruption of ERK kinases and PKC signaling pathways in human vascular SMCs.
Xuereb JM; Sié P; Boneu B; Constans J
Thromb Haemost; 2000 Jul; 84(1):129-36. PubMed ID: 10928483
[TBL] [Abstract][Full Text] [Related]
17. Different action of heparin and fucoidan on arterial smooth muscle cell proliferation and thrombospondin and fibronectin metabolism.
Vischer P; Buddecke E
Eur J Cell Biol; 1991 Dec; 56(2):407-14. PubMed ID: 1802722
[TBL] [Abstract][Full Text] [Related]
18. Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin.
Liu Y; Suzuki YJ; Day RM; Fanburg BL
Circ Res; 2004 Sep; 95(6):579-86. PubMed ID: 15297378
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor alpha inhibits insulin-induced mitogenic signaling in vascular smooth muscle cells.
Goetze S; Kintscher U; Kawano H; Kawano Y; Wakino S; Fleck E; Hsueh WA; Law RE
J Biol Chem; 2000 Jun; 275(24):18279-83. PubMed ID: 10764814
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potential of a synthetic peptide inhibitor of nuclear factor of activated T cells as antirestenotic agent.
Yu H; Sliedregt-Bol K; Overkleeft H; van der Marel GA; van Berkel TJ; Biessen EA
Arterioscler Thromb Vasc Biol; 2006 Jul; 26(7):1531-7. PubMed ID: 16675727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
